Diagnosis of Clostridium Difficile INTRODUCTION Clostridium Difficile Infection is currently the most commonly found cause of diarrhoea in relation to antibiotic treatments in hospitals. Although C.difficile infections are common‚ there are only a limited methods of diagnosing accurately if a patient has been affected. I will be discussing methods of diagnosis‚ pros and cons and statistical facts regarding C.difficile infection. METHODS OF LABORATORY DIAGNOSIS There are several methods
Premium Clostridium difficile
Pestoff (2013b) identifies three relationships citizens have with public actors: interdependence‚ where they rely on each other; supplementary‚ where non-public agents substitute public actors; and complementary‚ where non-public agents add value to public service. Every day‚ citizens carry out activities that could not be carried out by the state‚ particularly in the areas of policing‚ health‚ and education. The benefits of co-production exist in most instances where the state is not directly involved
Premium
SUN Pharma Company was established as a partnership firm by Dilip Sanghvi & his family to manufacture pharmaceutical formulations at Vapi‚ Gujarat. The Company specializes in selected therapeutic segment to psychiatry‚ cardiology‚ neurology‚ gastroenterology‚ orthopedics‚ ophthalmology nephrology and diabetology. It also makes Active Pharmaceutical Ingredients such as warfarin‚ carbamazepine‚ etodolac ‚ clorazepate‚ anticancers‚ steroids‚ peptides‚ sex hormones‚ and controlled substances. It is
Premium Pharmacology Pharmacology Ranbaxy Laboratories
business strategy and whether to pursue an opportunity to expand the USON offering. Specifically‚ the plan would introduce similar programs to independent physicians in other specialties‚ including primary care‚ rheumatology‚ orthopedics or gastroenterology. In order to evaluate this business decision‚ it is first necessary to examine the USON model and the McKesson positioning within the changing US healthcare environment based on the six factors affecting innovation. The USON acquisition provided
Premium Medicine Strategic management Health care
Obstetric Cholestasis (OC) or Intraheptic Cholestasis of pregnancy is a disorder that is unique to pregnancy (Kelly and Nelson-Piercy‚ 2000).OC classically presents in the third trimester (Royal College of Obstetricians and Gynaecologists [RCOG]‚ 2006)‚ With maternal pruritus and raised bile acids (Geenes and Williamson‚ 2009).It is one of the few disorders of pregnancy that can affect both maternal well being and fetal outcome. OC usually resolves forty eight hours after delivery (Mays‚ 2010).
Premium Obstetrics Bile acid Pregnancy
(NUH) is a tertiary specialist hospital that provides advanced‚ leading-edge medical care and services. They have high tech facilities as well as well trained and committed staff and have wide range of medical specialists. It includes Cardiology‚ Gastroenterology and Hepatology‚ Obstetrics & Gynaecology‚ Oncology‚ Ophthalmology‚ Paediatrics and Orthopaedic Surgery. Moreover it was chosen by the Ministry of Health in 2007 to develop two new national specialist centres which are the National University
Premium Medicine Hospital Management
References: 1. Canadian Operating Room Nursing Journal‚ Mentoring The Magic Partnership‚ Shelia L. Allen RN‚ BSN‚ CNOR‚ CRNFA‚ December 2006 2. Gastroenterology Nursing‚ The Inspiring Leader‚ Effie Amerson MSN‚ RN‚ 2005 3. Gastroenterology Nursing‚ Mentoring‚ Kathy B. Bean PhD‚ RN‚ CGRN‚ APRN‚ BC‚ Editor‚ 2005
Premium Nursing Nurse
independent self-motivated practitioner. Currently‚ I work in an endoscopy department where I developed many standard operating procedure guidelines which are being utilized throughout the hospital. I am also planning to obtain my Society of Gastroenterology Nurses and Associates (SGNA) certification this year. Another certification workshop I plan to attend is a nurse management seminar in
Premium Bachelor's degree Higher education Academic degree
ORGANIZATIONAL BEHAVIOUR COMPANY NAME: OBS PHARMACEUTICAL TOPIC: MOTIVATION GROUP MEMBERS: AISHA HANIF AKHAI – 15802 MARIA ASHRAF – AREESHA ABRAR – JUMANA MUJTABA – YOUSUF ANIS – ABDULLAH – TABLE OF CONTENTS ACKNOWLEDGEMENT We feel highly blessed by Almighty Allah who provided us with the knowledge and creativity to successfully complete this report within a short spell of time. We would
Premium Clinical trial Strategic management Clinical research
and Efficacy of Fidaxomicin in the Treatment of Clostridium difficile Associated Diarrhea.” Therapeutic Advances in Gastroenterology. 2012.5(6): p 395-402: Ebscohost. 31 Mar 2014 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491684/ -Hickson‚ May. “Probiotics in The Prevention of Antibiotic-Associated Diarrhoea and Clostridium difficile Infection.” Therapeutic Advances in Gastroenterology. May 2011 v 4(3): p 185-197: Ebscohost. 1 Apr 2014 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105609/ -Horridge
Premium Clostridium difficile